查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1377949

止血剂市场：按类型、配方和应用分类 - 2023-2030 年全球预测

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

止血剂市场预计将从 2022 年的 30.5 亿美元增至 2030 年的 47.5 亿美元，预测期内年复合成长率为 5.67%。

全球止血剂市场

主要市场统计
基准年[2022] 30.5亿美元
预测年份 [2023] 32.3亿美元
预测年份 [2030] 47.5亿美元
年复合成长率（%） 5.67%
止血剂市场-IMG1

FPNV定位矩阵

FPNV定位矩阵是评估止血剂市场的必备工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.止血剂市场规模及预测如何？

2. 止血剂市场中哪些产品、细分市场、应用和领域具有最高投资潜力？

3.止血剂市场竞争策略的窗口是什么？

4.止血剂市场的最新技术趋势和法律规范是什么？

5.止血器市场主要厂商的市场占有率是多少？

6. 进入止血剂市场的适当型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率不断上升，需要手术干预
      • 人们对微创手术的兴趣日益浓厚
    • 抑制因素
      • 产品召回发生率增加
    • 机会
      • 基于生物聚合物的一次性产品止血剂的兴起
      • 整合奈米技术创造更有效率、更有针对性的止血剂
    • 任务
      • 使用止血工具和试剂相关的感染和交叉污染的风险
  • 市场区隔分析
    • 类型：扩大止血组合的使用，因为它们可以更有效地减少出血
    • 配方：止血剂，增加粉末在手术介入期间控制和预防出血的潜力
    • 应用：止血剂在心血管手术中防止失血并确保可靠结果的重要作用
  • 市场趋势分析
    • 美洲地区医疗保健结构稳健且改善，止血剂的供应也有所改善
    • 透过增加政府对亚太地区的投资，加速医疗旅游并扩大医疗基础设施
    • 医疗旅游业的成长以及主要医疗保健公司在欧洲、中东和非洲地区的稳固立足点
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章止血剂市场：按类型

  • 胶原蛋白止血剂
  • 组合止血器
  • 明胶止血剂
  • 氧化再生纤维素止血剂
  • 基于凝血酶的止血剂

第7章以剂型分類的止血剂市场

  • 基质和凝胶止血剂
  • 粉末止血剂
  • 片材和止血垫
  • 海绵止血剂

第8章止血剂市场：依应用分类

  • 心血管外科
  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科
  • 重组手术

第9章美洲止血剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太止血剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东及非洲止血剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 竞争情境分析：主要企业
    • 併购
    • 新产品发布和功能增强
    • 奖项/奖励/扩展

第13章竞争产品组合

  • 主要公司简介
    • AR Medicom, Inc.
    • ACTEON Group
    • Advamedica Inc.
    • Advanced Medical Solutions Group PLC
    • Advin Health Care
    • Aegis Lifesciences Private Limited
    • Argon Medical Devices
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Betatech Medical
    • Convatec Group PLC
    • Cook Group Incorporated
    • Cortis Medtech Pvt Ltd
    • Cotran Corporation
    • Dolphin Sutures by Futura Surgicare Pvt. Ltd.
    • Dynarex Corporation
    • Gelita AG
    • Hangzhou Singclean Medical Products Co.,Ltd.
    • Healthium Medtech Ltd
    • Hemostasis, LLC
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson Services, Inc.
    • Medcura, Inc.
    • Medline Industries, LP
    • Medprin Biotech GmbH
    • Medtronic PLC
    • Meril Life Sciences Pvt. Ltd.
    • Olympus Corporation
    • Pfizer Inc.
    • Rousselot BV by Darling Ingredients International Holding BV
    • Royal DSM
    • Shilpa Medicare Limited
    • Stapleline Medizintechnik GmbH
    • Stryker Corporation
    • SYMATESE
    • Teleflex Incorporated
    • Terumo Corporation
    • Zhejiang Perfectseal New Material Technology Co., Ltd.
    • Zimmer Biomet Holdings, Inc.
  • 主要产品系列

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-961BA04A2E37

The Hemostats Market is projected to reach USD 4.75 billion by 2030 from USD 3.05 billion in 2022, at a CAGR of 5.67% during the forecast period.

Global Hemostats Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.05 billion
Estimated Year [2023] USD 3.23 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.67%
Hemostats Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Hemostats Market.

Based on Type, market is studied across Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, and Thrombin-Based Hemostats. The Collagen-Based Hemostats commanded largest market share of 24.22% in 2022, followed by Gelatin-Based Hemostats.

Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats. The Sponge Hemostats commanded largest market share of 27.43% in 2022, followed by Sheet & Pad Hemostats.

Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery, Orthopedic Surgery, and Reconstructive Surgery. The Cardiovascular Surgery commanded largest market share of 23.25% in 2022, followed by Gynecological Surgery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.52% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Hemostats Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Hemostats Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Hemostats Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Hemostats Market?

3. What is the competitive strategic window for identifying opportunities in the Hemostats Market?

4. What are the latest technology trends and regulatory frameworks in the Hemostats Market?

5. What is the market share of the leading vendors in the Hemostats Market?

6. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Hemostats Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Market Trend Analysis
    • 5.3.1. Robust and improving healthcare infrastructure and availability of improved hemostats in the Americas region
    • 5.3.2. Acceleration of medical tourism and expanding healthcare infrastructure with growing investment by the government in the Asia-Pacific
    • 5.3.3. Increase in number of medical tourists coupled with strong foothold of major healthcare companies in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
      • 12.3.1.2. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. Baxter Launches PERCLOT Absorbable Hemostatic Powder
      • 12.3.2.2. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
      • 12.3.3.2. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
      • 12.3.3.3. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
      • 12.3.3.4. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
      • 12.3.3.5. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
      • 12.3.3.6. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. A.R. Medicom, Inc.
    • 13.1.2. ACTEON Group
    • 13.1.3. Advamedica Inc.
    • 13.1.4. Advanced Medical Solutions Group PLC
    • 13.1.5. Advin Health Care
    • 13.1.6. Aegis Lifesciences Private Limited
    • 13.1.7. Argon Medical Devices
    • 13.1.8. B. Braun SE
    • 13.1.9. Baxter International Inc.
    • 13.1.10. Becton, Dickinson and Company
    • 13.1.11. Betatech Medical
    • 13.1.12. Convatec Group PLC
    • 13.1.13. Cook Group Incorporated
    • 13.1.14. Cortis Medtech Pvt Ltd
    • 13.1.15. Cotran Corporation
    • 13.1.16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
    • 13.1.17. Dynarex Corporation
    • 13.1.18. Gelita AG
    • 13.1.19. Hangzhou Singclean Medical Products Co.,Ltd.
    • 13.1.20. Healthium Medtech Ltd
    • 13.1.21. Hemostasis, LLC
    • 13.1.22. Integra LifeSciences Holdings Corporation
    • 13.1.23. Johnson & Johnson Services, Inc.
    • 13.1.24. Medcura, Inc.
    • 13.1.25. Medline Industries, LP
    • 13.1.26. Medprin Biotech GmbH
    • 13.1.27. Medtronic PLC
    • 13.1.28. Meril Life Sciences Pvt. Ltd.
    • 13.1.29. Olympus Corporation
    • 13.1.30. Pfizer Inc.
    • 13.1.31. Rousselot BV by Darling Ingredients International Holding B.V.
    • 13.1.32. Royal DSM
    • 13.1.33. Shilpa Medicare Limited
    • 13.1.34. Stapleline Medizintechnik GmbH
    • 13.1.35. Stryker Corporation
    • 13.1.36. SYMATESE
    • 13.1.37. Teleflex Incorporated
    • 13.1.38. Terumo Corporation
    • 13.1.39. Zhejiang Perfectseal New Material Technology Co., Ltd.
    • 13.1.40. Zimmer Biomet Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HEMOSTATS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. HEMOSTATS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. HEMOSTATS MARKET DYNAMICS
  • FIGURE 7. HEMOSTATS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. HEMOSTATS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. HEMOSTATS MARKET SIZE, BY FORMULATION, 2022 VS 2030 (%)
  • FIGURE 10. HEMOSTATS MARKET SIZE, BY FORMULATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HEMOSTATS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. HEMOSTATS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 12. HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 151. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 152. HEMOSTATS MARKET LICENSE & PRICING